Market Introduction
Neuromodulation is the process of regulating the activity of nerves by controlling the physiological level of neurotransmitters. These modifications are brought about with the help of various devices or by drug infusion. These devices contain small electrodes that are placed on the spinal cord, brain or the peripheral nerves. Neurological disorders such as, cerebrovascular diseases, Alzheimer disease and Parkinson's disease affect the neurological functioning of the body and hence can be treated with the help of neuromodulation.
Market Overview and Dynamics
In the South & Central America, the Neuromodulation market is expected to reach US$ 627.22 million in 2027 from US$ 316.72 million in 2019; the market is estimated to grow at a CAGR of 9.2% from 2020 to 2027. The growth of the market is attributed to the increasing product launches in the market, the rising product innovation for neuromodulation devices and growing developments in neuromodulation technology. However, high cost of neuromodulation devices is likely to restraint the growth of the market during the forecast years.
Key Market Segments
In terms of technology, the External (Non-Invasive) Neuromodulation segment is expected to hold the largest share of the Neuromodulation market by 2027. In terms of application, the Chronic Pain Management held the most significant market share of the Neuromodulation market. In terms of the end user, the hospitals segment is expected to maintain its largest market share by 2027
Major Sources and Companies Listed
Some of the major primary and secondary sources for neuromodulation market included in the report are Mental Health Database, Neurological diseases databases, Alzheimer’s websites, and others.
Reasons to buy the report
SOUTH & CENTRAL AMERICA NEUROMODULATION MARKET SEGMENTATION
· External (Non-Invasive) Neuromodulation
o Respiratory Electrical Stimulation (RES)
o Transcutaneous Electrical Nerve Stimulation (TENS)
o Transcranial Magnetic Stimulation (TMS)
· Internal Neuromodulation
o Deep Brain Stimulation (DBS)
o Sacral Nerve Stimulation (SNS)
o Gastric Electrical Stimulation (GES)
o Spinal Cord Stimulation (SCS)
o Vagus Nerve Stimulation (VNS)
· Chronic Pain Management
· Failed Back Syndrome
· Epilepsy
· Tremor
· Incontinence
· Depression
· Dystonia
· Gastroparesis
· Parkinson’s Disease
· Obsessive-Compulsive Disorder
· Migraine
· Hospitals
· Clinics
· UAE
· Saudi Arabia
· South Africa
Company Profile-
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 316.72 Million |
| Market Size by 2027 | US$ 627.22 Million |
| CAGR (2020 - 2027) | 9.2% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South and Central America Neuromodulation Market is valued at US$ 316.72 Million in 2019, it is projected to reach US$ 627.22 Million by 2027.
As per our report South and Central America Neuromodulation Market, the market size is valued at US$ 316.72 Million in 2019, projecting it to reach US$ 627.22 Million by 2027. This translates to a CAGR of approximately 9.2% during the forecast period.
The South and Central America Neuromodulation Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America Neuromodulation Market report:
The South and Central America Neuromodulation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America Neuromodulation Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America Neuromodulation Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America Neuromodulation Market
